HEMOPHILIA B
Clinical trials for HEMOPHILIA B explained in plain language.
Never miss a new study
Get alerted when new HEMOPHILIA B trials appear
Sign up with your email to follow new studies for HEMOPHILIA B, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Study tracks Real-Life bleeding control in hemophilia b patients
Disease control CompletedThis study observed how well the medication Alprolix works for people with hemophilia B in their everyday lives. Researchers followed 151 patients for two years to see how often they experienced bleeding episodes and how much medication they used. The goal was to understand the r…
Matched conditions: HEMOPHILIA B
Sponsor: Swedish Orphan Biovitrum • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Patients and doctors share views on new gene therapy for bleeding disorder
Knowledge-focused CompletedThis study surveyed 150 hemophilia B patients, their caregivers, and healthcare workers worldwide to understand what they know and think about gene therapy. Researchers conducted interviews to learn about people's attitudes, concerns, and how they prefer to receive information ab…
Matched conditions: HEMOPHILIA B
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:28 UTC
-
Scientists gather data to pave way for hemophilia gene therapy
Knowledge-focused CompletedThis study aimed to collect detailed information on how well current standard treatments work for adults with severe hemophilia A or B. Researchers tracked bleeding rates and treatment use in 212 participants for at least six months. This data serves as a crucial baseline to comp…
Matched conditions: HEMOPHILIA B
Phase: PHASE3 • Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:37 UTC